{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:34:23Z","timestamp":1790555663577,"version":"4.1.0"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T00:00:00Z","timestamp":1469491200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1038\/nrurol.2016.134","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T10:20:56Z","timestamp":1469528456000},"page":"573-583","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Nocturia: aetiology and treatment in adults"],"prefix":"10.1038","volume":"13","author":[{"given":"Hasan","family":"Dani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashanda","family":"Esdaille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey P.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,26]]},"reference":[{"key":"BFnrurol2016134_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/nau.10053","volume":"21","author":"P van Kerrebroeck","year":"2002","unstructured":"van Kerrebroeck, P. et al. The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol. Urodyn. 21, 179\u2013183 (2002).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2016134_CR2","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.eururo.2009.03.080","volume":"57","author":"KA Tikkinen","year":"2010","unstructured":"Tikkinen, K. A. et al. Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland. Eur. Urol. 57, 488\u2013496 (2010).","journal-title":"Eur. Urol."},{"key":"BFnrurol2016134_CR3","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.juro.2010.09.108","volume":"185","author":"V Kupelian","year":"2011","unstructured":"Kupelian, V. et al. Association of nocturia and mortality: results from the Third National Health and Nutrition Examination Survey. J. Urol. 185, 571\u2013577 (2011).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR4","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/j.juro.2012.11.033","volume":"189","author":"JL Bosch","year":"2013","unstructured":"Bosch, J. L. & Weiss, J. P. The prevalence and causes of nocturia. J. Urol. 189, S86\u2013S92 (2013).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR5","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00192-006-0167-x","volume":"18","author":"FY Chen","year":"2007","unstructured":"Chen, F. Y. et al. Perception of nocturia and medical consulting behavior among community-dwelling women. Int. Urogynecol. J. Pelvic Floor Dysfunct. 18, 431\u2013436 (2007).","journal-title":"Int. Urogynecol. J. Pelvic Floor Dysfunct."},{"key":"BFnrurol2016134_CR6","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.urology.2015.08.006","volume":"86","author":"C Welliver","year":"2015","unstructured":"Welliver, C. et al. Analyzing why men seek treatment for lower urinary tract symptoms and factors associated with non-improvement. Urology 86, 862\u2013867 (2015).","journal-title":"Urology"},{"key":"BFnrurol2016134_CR7","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.juro.2006.11.057","volume":"177","author":"MP Fitzgerald","year":"2007","unstructured":"Fitzgerald, M. P., Litman, H. J., Link, C. L., McKinlay, J. B. & BACH Survey Investigators. The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey. J. Urol. 177, 1385\u20131389 (2007).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR8","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.eururo.2014.01.019","volume":"65","author":"A Agarwal","year":"2014","unstructured":"Agarwal, A. et al. What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women. Eur. Urol. 65, 1211\u20131217 (2014).","journal-title":"Eur. Urol."},{"key":"BFnrurol2016134_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.eururo.2014.12.012","volume":"68","author":"L Zhang","year":"2015","unstructured":"Zhang, L. et al. A population-based survey of the prevalence, potential risk factors, and symptom-specific bother of lower urinary tract symptoms in adult Chinese women. Eur. Urol. 68, 97\u2013112 (2015).","journal-title":"Eur. Urol."},{"key":"BFnrurol2016134_CR10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.5213\/inj.2014.18.2.86","volume":"18","author":"P Miranda Ede","year":"2014","unstructured":"Miranda Ede, P. et al. Nocturia is the lower urinary tract symptom with greatest impact on quality of life of men from a community setting. Int. Neurourol. J. 18, 86\u201390 (2014).","journal-title":"Int. Neurourol. J."},{"key":"BFnrurol2016134_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.urology.2015.04.036","volume":"86","author":"K Aikawa","year":"2015","unstructured":"Aikawa, K. et al. Elucidation of the pattern of the onset of male lower urinary tract symptoms using cluster analysis: efficacy of tamsulosin in each symptom group. Urology 86, 349\u2013353 (2015).","journal-title":"Urology"},{"key":"BFnrurol2016134_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1464-410X.2006.06493.x","volume":"98","author":"E Chartier-Kastler","year":"2006","unstructured":"Chartier-Kastler, E. & Chapple, C. R. LUTS\/BPH in clinical practice: the importance of nocturia and quality of sleep. BJU Int. 98, 3\u20138 (2006).","journal-title":"BJU Int."},{"key":"BFnrurol2016134_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.eururo.2011.05.065","volume":"61","author":"V Kupelian","year":"2012","unstructured":"Kupelian, V. et al. Nocturia and quality of life: results from the Boston area community health survey. Eur. Urol. 61, 78\u201384 (2012).","journal-title":"Eur. Urol."},{"key":"BFnrurol2016134_CR14","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.sleep.2008.04.002","volume":"10","author":"DL Bliwise","year":"2009","unstructured":"Bliwise, D. L. et al. Nocturia and disturbed sleep in the elderly. Sleep Med. 10, 540\u2013548 (2009).","journal-title":"Sleep Med."},{"key":"BFnrurol2016134_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.sleep.2015.01.021","volume":"16","author":"K Obayashi","year":"2015","unstructured":"Obayashi, K., Saeki, K. & Kurumatani, N. Quantitative association between nocturnal voiding frequency and objective sleep quality in the general elderly population: the HEIJO-KYO cohort. Sleep Med. 16, 577\u2013582 (2015).","journal-title":"Sleep Med."},{"key":"BFnrurol2016134_CR16","doi-asserted-by":"publisher","first-page":"e30969","DOI":"10.1371\/journal.pone.0030969","volume":"7","author":"S Parthasarathy","year":"2012","unstructured":"Parthasarathy, S. et al. Nocturia, sleep-disordered breathing, and cardiovascular morbidity in a community-based cohort. PLoS ONE 7, e30969 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrurol2016134_CR17","first-page":"319","volume":"5","author":"SA Keenan","year":"1999","unstructured":"Keenan, S. A. Normal human sleep. Respir. Care Clin. N. Am. 5, 319\u2013331 (1999).","journal-title":"Respir. Care Clin. N. Am."},{"key":"BFnrurol2016134_CR18","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1073\/pnas.0706446105","volume":"105","author":"E Tasali","year":"2008","unstructured":"Tasali, E., Leproult, R., Ehrmann, D. A. & Van Cauter, E. Slow-wave sleep and the risk of type 2 diabetes in humans. Proc. Natl Acad. Sci. USA 105, 1044\u20131049 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrurol2016134_CR19","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.psyneuen.2013.03.018","volume":"38","author":"N Herzog","year":"2013","unstructured":"Herzog, N. et al. Selective slow wave sleep but not rapid eye movement sleep suppression impairs morning glucose tolerance in healthy men. Psychoneuroendocrinology 38, 2075\u20132082 (2013).","journal-title":"Psychoneuroendocrinology"},{"key":"BFnrurol2016134_CR20","doi-asserted-by":"publisher","unstructured":"Cedernaes, J. et al. A single night of partial sleep loss impairs fasting insulin sensitivity but does not affect cephalic phase insulin release in young men. J. Sleep Res. http:\/\/dx.doi.org\/10.1111\/jsr.12340 (2015).","DOI":"10.1111\/jsr.12340"},{"key":"BFnrurol2016134_CR21","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1164\/rccm.201501-0046OC","volume":"192","author":"HA Chami","year":"2015","unstructured":"Chami, H. A., Gottlieb, D. J., Redline, S. & Punjabi, N. M. Association between glucose metabolism and sleep-disordered breathing during REM sleep. Am. J. Respir. Crit. Care Med. 192, 1118\u20131126 (2015).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrurol2016134_CR22","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.sleep.2013.04.017","volume":"14","author":"PA Kudlow","year":"2013","unstructured":"Kudlow, P. A., Cha, D. S., Lam, R. W. & McIntyre, R. S. Sleep architecture variation: a mediator of metabolic disturbance in individuals with major depressive disorder. Sleep Med. 14, 943\u2013949 (2013).","journal-title":"Sleep Med."},{"key":"BFnrurol2016134_CR23","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1161\/HYPERTENSIONAHA.111.174409","volume":"58","author":"MM Fung","year":"2011","unstructured":"Fung, M. M. et al. Decreased slow wave sleep increases risk of developing hypertension in elderly men. Hypertension 58, 596\u2013603 (2011).","journal-title":"Hypertension"},{"key":"BFnrurol2016134_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.eururo.2007.01.027","volume":"52","author":"P van Kerrebroeck","year":"2007","unstructured":"van Kerrebroeck, P. et al. Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study. Eur. Urol. 52, 221\u2013229 (2007).","journal-title":"Eur. Urol."},{"key":"BFnrurol2016134_CR25","doi-asserted-by":"publisher","first-page":"e557","DOI":"10.1016\/j.juro.2013.02.2717","volume":"189","author":"K Torimoto","year":"2013","unstructured":"Torimoto, K. et al. Evaluation of sleep quantity and quality in older adults with nocturia using portable electroencephalogram acquisition. J. Urol. 189, e557\u2013e558 (2013).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR26","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.5665\/sleep.5154","volume":"38","author":"PH Finan","year":"2015","unstructured":"Finan, P. H., Quartana, P. J. & Smith, M. T. The effects of sleep continuity disruption on positive mood and sleep architecture in healthy adults. Sleep 38, 1735\u20131742 (2015).","journal-title":"Sleep"},{"key":"BFnrurol2016134_CR27","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/nau.22724","volume":"34","author":"DL Bliwise","year":"2015","unstructured":"Bliwise, D. L., Dijk, D. J. & Juul, K. V. Nocturia is associated with loss of deep sleep independently from sleep apnea. Neurourol. Urodyn. 34, 392 (2015).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2016134_CR28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5664\/jcsm.4364","volume":"11","author":"DL Bliwise","year":"2015","unstructured":"Bliwise, D. L., Holm-Larsen, T., Goble, S. & Norgaard, J. P. Short time to first void is associated with lower whole-night sleep quality in nocturia patients. J. Clin. Sleep Med. 11, 53\u201355 (2015).","journal-title":"J. Clin. Sleep Med."},{"key":"BFnrurol2016134_CR29","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.sleep.2014.05.013","volume":"15","author":"DL Bliwise","year":"2014","unstructured":"Bliwise, D. L., Holm-Larsen, T. & Goble, S. Increases in duration of first uninterrupted sleep period are associated with improvements in PSQI-measured sleep quality. Sleep Med. 15, 1276\u20131278 (2014).","journal-title":"Sleep Med."},{"key":"BFnrurol2016134_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse, D. J., Reynolds, C. F. 3rd, Monk, T. H., Berman, S. R. & Kupfer, D. J. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 28, 193\u2013213 (1989).","journal-title":"Psychiatry Res."},{"key":"BFnrurol2016134_CR31","doi-asserted-by":"publisher","first-page":"e550","DOI":"10.1016\/S1569-9056(15)60543-7","volume":"14","author":"D Bliwise","year":"2015","unstructured":"Bliwise, D., Juul, K. V., Larsen, T., Van der Meulen, E. & Norgaard, J. P. Increase in first undisturbed sleep period (FUSP) is associated with a reduction in random blood glucose in nocturia patients. Eur. Urol. Suppl. 14, e550\u2013e550a (2015).","journal-title":"Eur. Urol. Suppl."},{"key":"BFnrurol2016134_CR32","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/j.1464-410X.2011.10806.x","volume":"110","author":"DJ Lightner","year":"2012","unstructured":"Lightner, D. J. et al. Nocturia is associated with an increased risk of coronary heart disease and death. BJU Int. 110, 848\u2013853 (2012).","journal-title":"BJU Int."},{"key":"BFnrurol2016134_CR33","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.amjcard.2006.06.024","volume":"98","author":"M Bursztyn","year":"2006","unstructured":"Bursztyn, M., Jacob, J. & Stessman, J. Usefulness of nocturia as a mortality risk factor for coronary heart disease among persons born in 1920 or 1921. Am. J. Cardiol. 98, 1311\u20131315 (2006).","journal-title":"Am. J. Cardiol."},{"key":"BFnrurol2016134_CR34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ijcard.2015.03.168","volume":"195","author":"Y Fan","year":"2015","unstructured":"Fan, Y., Wei, F., Lang, Y. & Qi, W. Meta-analysis of nocturia and risk of all-cause mortality in adult population. Int. J. Cardiol. 195, 120\u2013122 (2015).","journal-title":"Int. J. Cardiol."},{"key":"BFnrurol2016134_CR35","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.juro.2010.05.093","volume":"184","author":"H Nakagawa","year":"2010","unstructured":"Nakagawa, H. et al. Impact of nocturia on bone fracture and mortality in older individuals: a Japanese longitudinal cohort study. J. Urol. 184, 1413\u20131418 (2010).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR36","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/j.juro.2011.12.078","volume":"187","author":"B van Doorn","year":"2012","unstructured":"van Doorn, B., Kok, E. T., Blanker, M. H., Westers, P. & Bosch, J. L. Mortality in older men with nocturia. A 15-year followup of the Krimpen study. J. Urol. 187, 1727\u20131731 (2012).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1464-410X.2008.08317.x","volume":"104","author":"JK Parsons","year":"2009","unstructured":"Parsons, J. K. et al. Lower urinary tract symptoms increase the risk of falls in older men. BJU Int. 104, 63\u201368 (2009).","journal-title":"BJU Int."},{"key":"BFnrurol2016134_CR38","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/nau.20712","volume":"28","author":"C Temml","year":"2009","unstructured":"Temml, C. et al. Nocturia is an age-independent risk factor for hip-fractures in men. Neurourol. Urodyn. 28, 949\u2013952 (2009).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2016134_CR39","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/sleep\/33.5.585","volume":"33","author":"FP Cappuccio","year":"2010","unstructured":"Cappuccio, F. P., D'Elia, L., Strazzullo, P. & Miller, M. A. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep 33, 585\u2013592 (2010).","journal-title":"Sleep"},{"key":"BFnrurol2016134_CR40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/01.PSY.0000039756.23250.7C","volume":"65","author":"MA Dew","year":"2003","unstructured":"Dew, M. A. et al. Healthy older adults' sleep predicts all-cause mortality at 4 to 19 years of follow-up. Psychosom. Med. 65, 63\u201373 (2003).","journal-title":"Psychosom. Med."},{"key":"BFnrurol2016134_CR41","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.sleep.2012.04.010","volume":"13","author":"KE Ensrud","year":"2012","unstructured":"Ensrud, K. E. et al. Sleep disturbances and risk of frailty and mortality in older men. Sleep Med. 13, 1217\u20131225 (2012).","journal-title":"Sleep Med."},{"key":"BFnrurol2016134_CR42","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/aje\/kwp133","volume":"170","author":"KA Tikkinen","year":"2009","unstructured":"Tikkinen, K. A. et al. A systematic evaluation of factors associated with nocturia \u2014 the population-based FINNO study. Am. J. Epidemiol. 170, 361\u2013368 (2009).","journal-title":"Am. J. Epidemiol."},{"key":"BFnrurol2016134_CR43","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.juro.2009.04.025","volume":"182","author":"V Kupelian","year":"2009","unstructured":"Kupelian, V. et al. Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey. J. Urol. 182, 616\u2013624; discussion 624\u2013625 (2009).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR44","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.urology.2011.05.033","volume":"78","author":"CH Liao","year":"2011","unstructured":"Liao, C. H., Chiang, H. S. & Yu, H. J. Serum testosterone levels significantly correlate with nocturia in men aged 40\u201379 years. Urology 78, 631\u2013635 (2011).","journal-title":"Urology"},{"key":"BFnrurol2016134_CR45","doi-asserted-by":"publisher","first-page":"153.e1","DOI":"10.1016\/j.ajog.2008.03.054","volume":"199","author":"KA Tikkinen","year":"2008","unstructured":"Tikkinen, K. A. et al. Reproductive factors associated with nocturia and urinary urgency in women: a population-based study in Finland. Am. J. Obstet. Gynecol. 199, 153.e1\u2013153.e12 (2008).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BFnrurol2016134_CR46","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1007\/s00345-015-1560-1","volume":"33","author":"II Bouwman","year":"2015","unstructured":"Bouwman, I. I. et al. Do lower urinary tract symptoms predict cardiovascular diseases in older men? A systematic review and meta-analysis. World J. Urol. 33, 1911\u20131920 (2015).","journal-title":"World J. Urol."},{"key":"BFnrurol2016134_CR47","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nrneph.2015.89","volume":"11","author":"D Bockenhauer","year":"2015","unstructured":"Bockenhauer, D. & Bichet, D. G. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus. Nat. Rev. Nephrol. 11, 576\u2013588 (2015).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrurol2016134_CR48","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1365-2796.2006.01760.x","volume":"261","author":"S Nielsen","year":"2007","unstructured":"Nielsen, S., Kwon, T. H., Frokiaer, J. & Agre, P. Regulation and dysregulation of aquaporins in water balance disorders. J. Intern. Med. 261, 53\u201364 (2007).","journal-title":"J. Intern. Med."},{"key":"BFnrurol2016134_CR49","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1002\/nau.22594","volume":"33","author":"JG Verbalis","year":"2014","unstructured":"Verbalis, J. G. Renal physiology of nocturia. Neurourol. Urodyn. 33, S6\u2013S9 (2014).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2016134_CR50","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.juro.2013.10.100","volume":"191","author":"I Hofmeester","year":"2014","unstructured":"Hofmeester, I. et al. The association between nocturia and nocturnal polyuria in clinical and epidemiological studies: a systematic review and meta-analyses. J. Urol. 191, 1028\u20131033 (2014).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR51","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/j.1464-410X.2010.09763.x","volume":"107","author":"DM Gulur","year":"2011","unstructured":"Gulur, D. M., Mevcha, A. M. & Drake, M. J. Nocturia as a manifestation of systemic disease. BJU Int. 107, 702\u2013713 (2011).","journal-title":"BJU Int."},{"key":"BFnrurol2016134_CR52","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev.me.39.020188.002233","volume":"39","author":"GL Robertson","year":"1988","unstructured":"Robertson, G. L. Differential diagnosis of polyuria. Annu. Rev. Med. 39, 425\u2013442 (1988).","journal-title":"Annu. Rev. Med."},{"key":"BFnrurol2016134_CR53","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S0140-6736(13)60734-5","volume":"383","author":"AS Jordan","year":"2014","unstructured":"Jordan, A. S., McSharry, D. G. & Malhotra, A. Adult obstructive sleep apnoea. Lancet 383, 736\u2013747 (2014).","journal-title":"Lancet"},{"key":"BFnrurol2016134_CR54","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jjcc.2010.08.001","volume":"56","author":"Y Saito","year":"2010","unstructured":"Saito, Y. Roles of atrial natriuretic peptide and its therapeutic use. J. Cardiol. 56, 262\u2013270 (2010).","journal-title":"J. Cardiol."},{"key":"BFnrurol2016134_CR55","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.juro.2014.11.055","volume":"193","author":"MW Witthaus","year":"2015","unstructured":"Witthaus, M. W. et al. Bladder oxidative stress in sleep apnea contributes to detrusor instability and nocturia. J. Urol. 193, 1692\u20131699 (2015).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR56","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1016\/j.juro.2013.12.043","volume":"191","author":"K Obayashi","year":"2014","unstructured":"Obayashi, K., Saeki, K. & Kurumatani, N. Association between melatonin secretion and nocturia in elderly individuals: a cross-sectional study of the HEIJO-KYO cohort. J. Urol. 191, 1816\u20131821 (2014).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR57","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.urology.2015.07.047","volume":"87","author":"JW Kim","year":"2016","unstructured":"Kim, J. W. Effect of shift work on nocturia. Urology 87, 153\u2013160 (2016).","journal-title":"Urology"},{"key":"BFnrurol2016134_CR58","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-1156-7","volume-title":"Nocturia: Causes, Consequences and Clinical Approaches","author":"JP Weiss","year":"2012","unstructured":"Weiss, J. P. Nocturia: Causes, Consequences and Clinical Approaches (Springer, 2012)."},{"key":"BFnrurol2016134_CR59","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams, P. et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-Committee of the International Continence Society. Neurourol. Urodyn. 21, 167\u2013178 (2002).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2016134_CR60","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0022-5347(05)00067-4","volume":"175","author":"H Hashim","year":"2006","unstructured":"Hashim, H. & Abrams, P. Is the bladder a reliable witness for predicting detrusor overactivity? J. Urol. 175, 191\u2013194; discussion 194\u2013195 (2006).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR61","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/iju.12954","volume":"23","author":"AA Al-Zahrani","year":"2016","unstructured":"Al-Zahrani, A. A. & Gajewski, J. Urodynamic findings in women with refractory overactive bladder symptoms. Int. J. Urol. 23, 75\u201379 (2016).","journal-title":"Int. J. Urol."},{"key":"BFnrurol2016134_CR62","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/nau.20093","volume":"24","author":"G Matharu","year":"2005","unstructured":"Matharu, G., Donaldson, M. M., McGrother, C. W. & Matthews, R. J. Relationship between urinary symptoms reported in a postal questionnaire and urodynamic diagnosis. Neurourol. Urodyn. 24, 100\u2013105 (2005).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2016134_CR63","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.juro.2010.03.148","volume":"184","author":"AD Krystal","year":"2010","unstructured":"Krystal, A. D., Preud'homme, X. A., Amundsen, C. L. & Webster, G. D. Detrusor overactivity persisting at night and preceding nocturia in patients with overactive bladder syndrome: a nocturnal cystometrogram and polysomnogram study. J. Urol. 184, 623\u2013628 (2010).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR64","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.eururo.2008.02.017","volume":"54","author":"M Oelke","year":"2008","unstructured":"Oelke, M. et al. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia. Eur. Urol. 54, 419\u2013426 (2008).","journal-title":"Eur. Urol."},{"key":"BFnrurol2016134_CR65","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.urology.2010.05.034","volume":"77","author":"MM Oh","year":"2011","unstructured":"Oh, M. M. et al. Is there a correlation between the presence of idiopathic detrusor overactivity and the degree of bladder outlet obstruction? Urology 77, 167\u2013170 (2011).","journal-title":"Urology"},{"key":"BFnrurol2016134_CR66","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.juro.2013.07.011","volume":"191","author":"AB Araujo","year":"2014","unstructured":"Araujo, A. B. et al. Sleep related problems and urological symptoms: testing the hypothesis of bidirectionality in a longitudinal, population based study. J. Urol. 191, 100\u2013106 (2014).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR67","doi-asserted-by":"publisher","first-page":"e800","DOI":"10.1016\/j.juro.2013.02.2373","volume":"189","author":"JM Weinberger","year":"2013","unstructured":"Weinberger, J. M., Weiss, J. P., Kashan, M. & Blaivas, J. G. Nocturia: why do people void at night? J. Urol. 189, e800\u2013e801 (2013).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR68","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.eururo.2012.07.004","volume":"62","author":"JN Cornu","year":"2012","unstructured":"Cornu, J. N. et al. A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management \u2014 a systematic review and meta-analysis. Eur. Urol. 62, 877\u2013890 (2012).","journal-title":"Eur. Urol."},{"key":"BFnrurol2016134_CR69","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/(SICI)1520-6777(1998)17:5<467::AID-NAU2>3.0.CO;2-B","volume":"17","author":"JP Weiss","year":"1998","unstructured":"Weiss, J. P., Blaivas, J. G., Stember, D. S. & Brooks, M. M. Nocturia in adults: etiology and classification. Neurourol. Urodyn. 17, 467\u2013472 (1998).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2016134_CR70","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.urology.2015.02.043","volume":"85","author":"SD Marshall","year":"2015","unstructured":"Marshall, S. D. et al. Nocturia: current levels of evidence and recommendations from the International Consultation on Male Lower Urinary Tract Symptoms. Urology 85, 1291\u20131299 (2015).","journal-title":"Urology"},{"key":"BFnrurol2016134_CR71","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/nau.22410","volume":"33","author":"EP van Haarst","year":"2014","unstructured":"van Haarst, E. P. & Bosch, J. L. The optimal duration of frequency-volume charts related to compliance and reliability. Neurourol. Urodyn. 33, 296\u2013301 (2014).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2016134_CR72","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/nau.20924","volume":"30","author":"C Burton","year":"2011","unstructured":"Burton, C., Weiss, J. P., Parsons, M., Blaivas, J. G. & Coats, A. C. Reference values for the Nocturnal Bladder Capacity Index. Neurourol. Urodyn. 30, 52\u201357 (2011).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2016134_CR73","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/bju.12753","volume":"115","author":"I Hofmeester","year":"2015","unstructured":"Hofmeester, I. et al. Impact of the International Continence Society (ICS) report on the standardisation of terminology in nocturia on the quality of reports on nocturia and nocturnal polyuria: a systematic review. BJU Int. 115, 520\u2013536 (2015).","journal-title":"BJU Int."},{"key":"BFnrurol2016134_CR74","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.eururo.2014.09.003","volume":"67","author":"AS Goessaert","year":"2015","unstructured":"Goessaert, A. S., Krott, L., Hoebeke, P., Vande Walle, J. & Everaert, K. Diagnosing the pathophysiologic mechanisms of nocturnal polyuria. Eur. Urol. 67, 283\u2013288 (2015).","journal-title":"Eur. Urol."},{"key":"BFnrurol2016134_CR75","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.eururo.2012.10.004","volume":"63","author":"B van Doorn","year":"2013","unstructured":"van Doorn, B., Blanker, M. H., Kok, E. T., Westers, P. & Bosch, J. L. Prevalence, incidence, and resolution of nocturnal polyuria in a longitudinal community-based study in older men: the Krimpen study. Eur. Urol. 63, 542\u2013547 (2013).","journal-title":"Eur. Urol."},{"key":"BFnrurol2016134_CR76","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.juro.2012.04.112","volume":"188","author":"EP van Haarst","year":"2012","unstructured":"van Haarst, E. P. & Bosch, J. L. A cutoff value based on analysis of a reference population decreases overestimation of the prevalence of nocturnal polyuria. J. Urol. 188, 869\u2013873 (2012).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR77","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.urology.2003.10.019","volume":"63","author":"L Abraham","year":"2004","unstructured":"Abraham, L. et al. Development and validation of a quality-of-life measure for men with nocturia. Urology 63, 481\u2013486 (2004).","journal-title":"Urology"},{"key":"BFnrurol2016134_CR78","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/nau.22243","volume":"31","author":"JP Weiss","year":"2012","unstructured":"Weiss, J. P., Zinner, N. R., Klein, B. M. & Norgaard, J. P. Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial. Neurourol. Urodyn. 31, 441\u2013447 (2012).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2016134_CR79","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/nau.21186","volume":"31","author":"SY Cho","year":"2012","unstructured":"Cho, S. Y. et al. Short-term effects of systematized behavioral modification program for nocturia: a prospective study. Neurourol. Urodyn. 31, 64\u201368 (2012).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2016134_CR80","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1253\/circj.CJ-15-0654","volume":"79","author":"T Miyazaki","year":"2015","unstructured":"Miyazaki, T. et al. Nocturia in patients with sleep-disordered breathing and cardiovascular disease. Circ. J. 79, 2632\u20132640 (2015).","journal-title":"Circ. J."},{"key":"BFnrurol2016134_CR81","doi-asserted-by":"publisher","first-page":"178","DOI":"10.5213\/inj.2015.19.3.178","volume":"19","author":"T Wang","year":"2015","unstructured":"Wang, T., Huang, W., Zong, H. & Zhang, Y. The efficacy of continuous positive airway pressure therapy on nocturia in patients with obstructive sleep apnea: a systematic review and meta-analysis. Int. Neurourol. J. 19, 178\u2013184 (2015).","journal-title":"Int. Neurourol. J."},{"key":"BFnrurol2016134_CR82","first-page":"333","volume":"85","author":"M Miyazato","year":"2015","unstructured":"Miyazato, M. et al. Effect of continuous positive airway pressure on nocturnal urine production in patients with obstructive sleep apnea syndrome. Neurourol. Urodyn. 85, 333\u2013336 (2015).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2016134_CR83","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1046\/j.1464-410X.1998.00511.x","volume":"81","author":"JM Reynard","year":"1998","unstructured":"Reynard, J. M., Cannon, A., Yang, Q. & Abrams, P. A novel therapy for nocturnal polyuria: a double-blind randomized trial of frusemide against placebo. Br. J. Urol. 81, 215\u2013218 (1998).","journal-title":"Br. J. Urol."},{"key":"BFnrurol2016134_CR84","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S1043-6618(05)80059-3","volume":"25","author":"CA Maggi","year":"1992","unstructured":"Maggi, C. A. Prostanoids as local modulators of reflex micturition. Pharmacol. Res. 25, 13\u201320 (1992).","journal-title":"Pharmacol. Res."},{"key":"BFnrurol2016134_CR85","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.eururo.2005.11.026","volume":"49","author":"SK Addla","year":"2006","unstructured":"Addla, S. K., Adeyoju, A. B., Neilson, D. & O'Reilly, P. Diclofenac for treatment of nocturia caused by nocturnal polyuria: a prospective, randomised, double-blind, placebo-controlled crossover study. Eur. Urol. 49, 720\u2013725 (2006).","journal-title":"Eur. Urol."},{"key":"BFnrurol2016134_CR86","doi-asserted-by":"publisher","first-page":"f6259","DOI":"10.1136\/bmj.f6259","volume":"347","author":"PH Caldwell","year":"2013","unstructured":"Caldwell, P. H., Deshpande, A. V. & Von Gontard, A. Management of nocturnal enuresis. BMJ 347, f6259 (2013).","journal-title":"BMJ"},{"key":"BFnrurol2016134_CR87","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0022-3565(25)23723-5","volume":"234","author":"M Hammer","year":"1985","unstructured":"Hammer, M. & Vilhardt, H. Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin. J. Pharmacol. Exp. Ther. 234, 754\u2013760 (1985).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnrurol2016134_CR88","volume-title":"Pharmacologic treatment of urinary incontinence","author":"KC Andersson","year":"2013","unstructured":"Andersson, K. C. et al. Pharmacologic treatment of urinary incontinence (eds Abrams, P. C. et al.) (EAU-ICUD, 2013)."},{"key":"BFnrurol2016134_CR89","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.eururo.2013.03.004","volume":"64","author":"M Oelke","year":"2013","unstructured":"Oelke, M. et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur. Urol. 64, 118\u2013140 (2013).","journal-title":"Eur. Urol."},{"key":"BFnrurol2016134_CR90","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.juro.2014.03.095","volume":"192","author":"MH Ebell","year":"2014","unstructured":"Ebell, M. H., Radke, T. & Gardner, J. A systematic review of the efficacy and safety of desmopressin for nocturia in adults. J. Urol. 192, 829\u2013835 (2014).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR91","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/nau.22306","volume":"32","author":"KV Juul","year":"2013","unstructured":"Juul, K. V., Klein, B. M. & Norgaard, J. P. Long-term durability of the response to desmopressin in female and male nocturia patients. Neurourol. Urodyn. 32, 363\u2013370 (2013).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2016134_CR92","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.juro.2012.12.112","volume":"190","author":"JP Weiss","year":"2013","unstructured":"Weiss, J. P., Herschorn, S., Albei, C. D. & van der Meulen, E. A. Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. J. Urol. 190, 965\u2013972 (2013).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR93","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.juro.2013.02.037","volume":"190","author":"PK Sand","year":"2013","unstructured":"Sand, P. K., Dmochowski, R. R., Reddy, J. & van der Meulen, E. A. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. J. Urol. 190, 958\u2013964 (2013).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR94","doi-asserted-by":"publisher","first-page":"F1116","DOI":"10.1152\/ajprenal.00741.2010","volume":"300","author":"KV Juul","year":"2011","unstructured":"Juul, K. V., Klein, B. M., Sandstrom, R., Erichsen, L. & Norgaard, J. P. Gender difference in antidiuretic response to desmopressin. Am. J. Physiol. Renal Physiol. 300, F1116\u2013F1122 (2011).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrurol2016134_CR95","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1464-410X.2012.11547.x","volume":"111","author":"O Yamaguchi","year":"2013","unstructured":"Yamaguchi, O., Nishizawa, O., Juul, K. V. & Norgaard, J. P. Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial. BJU Int. 111, 474\u2013484 (2013).","journal-title":"BJU Int."},{"key":"BFnrurol2016134_CR96","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/nau.20168","volume":"25","author":"A Rembratt","year":"2006","unstructured":"Rembratt, A., Riis, A. & Norgaard, J. P. Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia. Neurourol. Urodyn. 25, 105\u2013109 (2006).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2016134_CR97","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/j.juro.2007.07.013","volume":"178","author":"TM Johnson","year":"2007","unstructured":"Johnson, T. M. et al. The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia. J. Urol. 178, 2045\u20132050; discussion 2050\u20132051 (2007).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR98","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00345-013-1228-7","volume":"32","author":"A Eisenhardt","year":"2014","unstructured":"Eisenhardt, A., Schneider, T., Cruz, F. & Oelke, M. Consistent and significant improvement of nighttime voiding frequency (nocturia) with silodosin in men with LUTS suggestive of BPH: pooled analysis of three randomized, placebo-controlled, double-blind phase III studies. World J. Urol. 32, 1119\u20131125 (2014).","journal-title":"World J. Urol."},{"key":"BFnrurol2016134_CR99","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/01.ju.0000069827.09120.79","volume":"170","author":"TM Johnson","year":"2003","unstructured":"Johnson, T. M. et al. Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial. J. Urol. 170, 145\u2013148 (2003).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR100","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1046\/j.1464-410X.2003.04309.x","volume":"92","author":"CG Roehrborn","year":"2003","unstructured":"Roehrborn, C. G., Van Kerrebroeck, P. & Nordling, J. Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies. BJU Int. 92, 257\u2013261 (2003).","journal-title":"BJU Int."},{"key":"BFnrurol2016134_CR101","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/iju.12669","volume":"22","author":"T Tanaka","year":"2015","unstructured":"Tanaka, T. et al. Efficacy of naftopidil for nocturia in male patients with lower urinary tract symptoms: comparison of morning and evening dosing. Int. J. Urol. 22, 317\u2013321 (2015).","journal-title":"Int. J. Urol."},{"key":"BFnrurol2016134_CR102","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00345-014-1255-z","volume":"32","author":"M Oelke","year":"2014","unstructured":"Oelke, M. et al. Effects of tadalafil on nighttime voiding (nocturia) in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a post hoc analysis of pooled data from four randomized, placebo-controlled clinical studies. World J. Urol. 32, 1127\u20131132 (2014).","journal-title":"World J. Urol."},{"key":"BFnrurol2016134_CR103","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s00345-014-1316-3","volume":"32","author":"M Oelke","year":"2014","unstructured":"Oelke, M. et al. Impact of dutasteride on nocturia in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS\/BPH): a pooled analysis of three phase III studies. World J. Urol. 32, 1141\u20131147 (2014).","journal-title":"World J. Urol."},{"key":"BFnrurol2016134_CR104","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00345-014-1296-3","volume":"32","author":"M Oelke","year":"2014","unstructured":"Oelke, M. et al. Nocturia improvement in the combination of Avodart(\u00ae) and tamsulosin (CombAT) study. World J. Urol. 32, 1133\u20131140 (2014).","journal-title":"World J. Urol."},{"key":"BFnrurol2016134_CR105","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.urology.2008.04.069","volume":"72","author":"S Falahatkar","year":"2008","unstructured":"Falahatkar, S., Mokhtari, G., Pourreza, F., Asgari, S. A. & Kamran, A. N. Celecoxib for treatment of nocturia caused by benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled study. Urology 72, 813\u2013816 (2008).","journal-title":"Urology"},{"key":"BFnrurol2016134_CR106","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1442-2042.2010.02704.x","volume":"18","author":"V Simaioforidis","year":"2011","unstructured":"Simaioforidis, V. et al. Tamsulosin versus transurethral resection of the prostate: effect on nocturia as a result of benign prostatic hyperplasia. Int. J. Urol. 18, 243\u2013248 (2011).","journal-title":"Int. J. Urol."},{"key":"BFnrurol2016134_CR107","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.urology.2014.05.040","volume":"84","author":"WS Choi","year":"2014","unstructured":"Choi, W. S., Ku, J. H., Oh, S. J., Kim, S. W. & Paick, J. S. Change of nocturnal polyuria after holmium laser enucleation of the prostate in patients with benign prostatic hyperplasia. Urology 84, 650\u2013656 (2014).","journal-title":"Urology"},{"key":"BFnrurol2016134_CR108","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/nau.10057","volume":"21","author":"R Machino","year":"2002","unstructured":"Machino, R. et al. Detrusor instability with equivocal obstruction: a predictor of unfavorable symptomatic outcomes after transurethral prostatectomy. Neurourol. Urodyn. 21, 444\u2013449 (2002).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2016134_CR109","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0022-5347(05)63949-3","volume":"169","author":"C de Nunzio","year":"2003","unstructured":"de Nunzio, C. et al. The evolution of detrusor overactivity after watchful waiting, medical therapy and surgery in patients with bladder outlet obstruction. J. Urol. 169, 535\u2013539 (2003).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR110","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.juro.2012.11.067","volume":"189","author":"JP Weiss","year":"2013","unstructured":"Weiss, J. P. et al. Efficacy and safety of flexible dose fesoterodine in men and women with overactive bladder symptoms including nocturnal urinary urgency. J. Urol. 189, 1396\u20131401 (2013).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR111","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.eururo.2012.08.060","volume":"62","author":"N Buser","year":"2012","unstructured":"Buser, N., Ivic, S., Kessler, T. M., Kessels, A. G. & Bachmann, L. M. Efficacy and adverse events of antimuscarinics for treating overactive bladder: network meta-analyses. Eur. Urol. 62, 1040\u20131060 (2012).","journal-title":"Eur. Urol."},{"key":"BFnrurol2016134_CR112","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.urology.2013.12.008","volume":"83","author":"O Yokoyama","year":"2014","unstructured":"Yokoyama, O., Hiro, S., Hotta, S., Mogami, S. & Yamagami, H. Efficacy of fesoterodine on nocturia and quality of sleep in Asian patients with overactive bladder. Urology 83, 750\u2013755 (2014).","journal-title":"Urology"},{"key":"BFnrurol2016134_CR113","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.urology.2005.10.061","volume":"67","author":"R Rackley","year":"2006","unstructured":"Rackley, R. et al. Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology 67, 731\u2013736; discussion 736 (2006).","journal-title":"Urology"},{"key":"BFnrurol2016134_CR114","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1001\/jama.296.19.2319","volume":"296","author":"SA Kaplan","year":"2006","unstructured":"Kaplan, S. A. et al. Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA 296, 2319\u20132328 (2006).","journal-title":"JAMA"},{"key":"BFnrurol2016134_CR115","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/bju.13267","volume":"117","author":"TH Kim","year":"2016","unstructured":"Kim, T. H. et al. Comparison of the efficacy and safety of 2 mg and 4 mg tolterodine combined with an alpha-blocker in men with lower urinary tract symptoms and overactive bladder: A randomised controlled trial. BJU Int. 117, 307\u2013315 (2016).","journal-title":"BJU Int."},{"key":"BFnrurol2016134_CR116","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00345-014-1399-x","volume":"33","author":"O Yokoyama","year":"2015","unstructured":"Yokoyama, O. et al. Add-on anticholinergic therapy for residual nocturia in patients with lower urinary tract symptoms receiving \u03b11-blocker treatment: a multi-centre, prospective, randomised study. World J. Urol. 33, 659\u2013667 (2015).","journal-title":"World J. Urol."},{"key":"BFnrurol2016134_CR117","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/j.1532-5415.2005.53260.x","volume":"53","author":"TM Johnson","year":"2005","unstructured":"Johnson, T. M. 2nd, Burgio, K. L., Redden, D. T., Wright, K. C. & Goode, P. S. Effects of behavioral and drug therapy on nocturia in older incontinent women. J. Am. Geriatr. Soc. 53, 846\u2013850 (2005).","journal-title":"J. Am. Geriatr. Soc."},{"key":"BFnrurol2016134_CR118","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.1464-410X.2012.11736.x","volume":"112","author":"TM Johnson","year":"2013","unstructured":"Johnson, T. M. et al. Efficacy of adding behavioural treatment or antimuscarinic drug therapy to \u03b1-blocker therapy in men with nocturia. BJU Int. 112, 100\u2013108 (2013).","journal-title":"BJU Int."},{"key":"BFnrurol2016134_CR119","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1002\/nau.22373","volume":"32","author":"CR Chapple","year":"2013","unstructured":"Chapple, C. R. et al. A proof-of-concept study: mirabegron, a new therapy for overactive bladder. Neurourol. Urodyn. 32, 1116\u20131122 (2013).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2016134_CR120","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/bju.13068","volume":"116","author":"O Yamaguchi","year":"2015","unstructured":"Yamaguchi, O. et al. Safety and efficacy of mirabegron as 'add-on' therapy in patients with overactive bladder treated with solifenacin: a post-marketing, open-label study in Japan (MILAI study). BJU Int. 116, 612\u2013622 (2015).","journal-title":"BJU Int."},{"key":"BFnrurol2016134_CR121","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/nau.22645","volume":"34","author":"HC Kuo","year":"2015","unstructured":"Kuo, H. C. et al. Results of a randomized, double-blind, parallel-group, placebo- and active-controlled, multicenter study of mirabegron, a \u03b23-adrenoceptor agonist, in patients with overactive bladder in Asia. Neurourol. Urodyn. 34, 685\u2013692 (2015).","journal-title":"Neurourol. Urodyn."},{"key":"BFnrurol2016134_CR122","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.juro.2012.10.017","volume":"189","author":"VW Nitti","year":"2013","unstructured":"Nitti, V. W. et al. Results of a randomized phase III trial of mirabegron in patients with overactive bladder. J. Urol. 189, 1388\u20131395 (2013).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR123","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.juro.2009.05.045","volume":"182","author":"KM Peters","year":"2009","unstructured":"Peters, K. M. et al. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J. Urol. 182, 1055\u20131061 (2009).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR124","doi-asserted-by":"publisher","unstructured":"Canbaz Kabay, S. et al. Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12-months results. Neurourol. Urodyn. http:\/\/dx.doi.org\/10.1002\/nau.22868 (2015).","DOI":"10.1002\/nau.22868"},{"key":"BFnrurol2016134_CR125","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.urology.2015.09.026","volume":"87","author":"S Kabay","year":"2016","unstructured":"Kabay, S. et al. The clinical and urodynamic results of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson's disease. Urology 87, 76\u201381 (2016).","journal-title":"Urology"},{"key":"BFnrurol2016134_CR126","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1007\/s11255-015-1125-7","volume":"47","author":"Y Sun","year":"2015","unstructured":"Sun, Y., Luo, D., Tang, C., Yang, L. & Shen, H. The safety and efficiency of onabotulinumtoxinA for the treatment of overactive bladder: a systematic review and meta-analysis. Int. Urol. Nephrol. 47, 1779\u20131788 (2015).","journal-title":"Int. Urol. Nephrol."},{"key":"BFnrurol2016134_CR127","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00345-012-0851-z","volume":"31","author":"A Hamidi Madani","year":"2013","unstructured":"Hamidi Madani, A. et al. Transurethral intraprostatic Botulinum toxin-A injection: a novel treatment for BPH refractory to current medical therapy in poor surgical candidates. World J. Urol. 31, 235\u2013239 (2013).","journal-title":"World J. Urol."},{"key":"BFnrurol2016134_CR128","first-page":"CD001044","volume":"1","author":"T Wilt","year":"2002","unstructured":"Wilt, T., Ishani, A., Mac Donald, R., Rutks, I. & Stark, G. Pygeum africanum for benign prostatic hyperplasia. Cochrane Database Syst. Rev. 1, CD001044 (2002).","journal-title":"Cochrane Database Syst. Rev."},{"key":"BFnrurol2016134_CR129","first-page":"CD001042","volume":"2","author":"T Wilt","year":"2000","unstructured":"Wilt, T., Mac Donald, R., Ishani, A., Rutks, I. & Stark, G. Cernilton for benign prostatic hyperplasia. Cochrane Database Syst. Rev. 2, CD001042 (2000).","journal-title":"Cochrane Database Syst. Rev."},{"key":"BFnrurol2016134_CR130","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1111\/j.1464-410X.2012.11172.x","volume":"109","author":"R MacDonald","year":"2012","unstructured":"MacDonald, R., Tacklind, J. W., Rutks, I. & Wilt, T. J. Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review. BJU Int. 109, 1756\u20131761 (2012).","journal-title":"BJU Int."},{"key":"BFnrurol2016134_CR131","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/j.1442-2042.2012.03095.x","volume":"19","author":"AF Chiu","year":"2012","unstructured":"Chiu, A. F., Huang, M. H., Wang, C. C. & Kuo, H. C. Higher glycosylated hemoglobin levels increase the risk of overactive bladder syndrome in patients with type 2 diabetes mellitus. Int. J. Urol. 19, 995\u20131001 (2012).","journal-title":"Int. J. Urol."},{"key":"BFnrurol2016134_CR132","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/jgs.12609","volume":"62","author":"S Tyagi","year":"2014","unstructured":"Tyagi, S. et al. Behavioral treatment of insomnia: also effective for nocturia. J. Am. Geriatr. Soc. 62, 54\u201360 (2014).","journal-title":"J. Am. Geriatr. Soc."},{"key":"BFnrurol2016134_CR133","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1177\/147323000703500513","volume":"35","author":"K Sugaya","year":"2007","unstructured":"Sugaya, K., Nishijima, S., Miyazato, M., Kadekawa, K. & Ogawa, Y. Effects of melatonin and rilmazafone on nocturia in the elderly. J. Int. Med. Res. 35, 685\u2013691 (2007).","journal-title":"J. Int. Med. Res."},{"key":"BFnrurol2016134_CR134","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1097\/01.ju.0000110442.47593.ea","volume":"171","author":"MJ Drake","year":"2004","unstructured":"Drake, M. J., Mills, I. W. & Noble, J. G. Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement. J. Urol. 171, 1199\u20131202 (2004).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR135","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1464-410X.2009.08353.x","volume":"104","author":"CP Vaughan","year":"2009","unstructured":"Vaughan, C. P., Endeshaw, Y., Nagamia, Z., Ouslander, J. G. & Johnson, T. M. A multicomponent behavioural and drug intervention for nocturia in elderly men: rationale and pilot results. BJU Int. 104, 69\u201374 (2009).","journal-title":"BJU Int."},{"key":"BFnrurol2016134_CR136","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-2490-13-30","volume":"13","author":"T Kawahara","year":"2013","unstructured":"Kawahara, T. et al. Ramelteon combined with an \u03b11-blocker decreases nocturia in men with benign prostatic hyperplasia. BMC Urol. 13, 30 (2013).","journal-title":"BMC Urol."},{"key":"BFnrurol2016134_CR137","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/luts.12001","volume":"5","author":"SW Doo","year":"2013","unstructured":"Doo, S. W., Kim, J. H., Yang, W. J. & Song, Y. S. Is there any objective improvement of nocturia by combination treatment of zolpidem and alpha-blocker therapy for unresponsive to alpha-blocker monotherapy in men with lower urinary tract symptoms? Low. Urin. Tract. Symptoms 5, 134\u2013139 (2013).","journal-title":"Low. Urin. Tract. Symptoms"},{"key":"BFnrurol2016134_CR138","doi-asserted-by":"publisher","first-page":"232","DOI":"10.5173\/ceju.2011.04.art9","volume":"64","author":"K Miwa","year":"2011","unstructured":"Miwa, K. et al. Efficacy of combination therapy with tamsulosin and zolpidem on nocturia in patients with benign prostatic hyperplasia. Cent. European J. Urol. 64, 232\u2013235 (2011).","journal-title":"Cent. European J. Urol."},{"key":"BFnrurol2016134_CR139","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.juro.2013.01.057","volume":"190","author":"WJ Bae","year":"2013","unstructured":"Bae, W. J. et al. Desmopressin add-on therapy for refractory nocturia in men receiving \u03b1-blockers for lower urinary tract symptoms. J. Urol. 190, 180\u2013186 (2013).","journal-title":"J. Urol."},{"key":"BFnrurol2016134_CR140","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5213\/inj.2014.18.4.213","volume":"18","author":"SY Cho","year":"2014","unstructured":"Cho, S. Y. et al. Effect of combined systematized behavioral modification education program with desmopressin in patients with nocturia: a prospective, multicenter, randomized, and parallel study. Int. Neurourol. J. 18, 213\u2013220 (2014).","journal-title":"Int. Neurourol. J."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2016.134.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2016.134","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2016.134.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T04:59:49Z","timestamp":1749013189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrurol.2016.134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,26]]},"references-count":140,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["BFnrurol2016134"],"URL":"https:\/\/doi.org\/10.1038\/nrurol.2016.134","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,26]]},"assertion":[{"value":"26 July 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.P.W. declares that he serves as consultant for Allergan, Astellas, Elsevier, Ferring, Pfizer, Symptelligence and Vantia. H.D. and A.E. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}